Introduction. Late nephrology referral is associated with adverse outcomes especially among minorities. Research on the association of the rate of chronic kidney disease (CKD) progression with nephrology referral in white versus black patients is lacking. Objectives. Compute the odds of nephrology referral in primary care and their associations with race and the rate of CKD progression. Methods. Electronic health record data were obtained from 2170 patients in primary care clinics in the Saint Louis metropolitan area with at least two estimated glomerular filtration rate (eGFR) values over a 7-year observation period. Fast CKD progression was defined as a decline in eGFR of ≥5 ml/min/1.73 m
Introduction
Chronic kidney disease (CKD) is a major world-wide health problem accounting for significant patient morbidity and mortality and health care costs (1, 2) . A large proportion of CKD, especially mild to moderate disease, is managed in the primary care physician's (PCP's) office and there is evidence of inadequate recognition and management of CKD in this setting (3) . Data suggests that there is room for improvement in the quality of management of CKD in primary care, including timely referral to nephrology (4, 5) .
In most studies, 'late referral' to a nephrologist is considered to be within 1-6 months of requirement of renal replacement therapy (RRT) (6) . Late and even a lack of any referral to nephrologists is unfortunately quite common worldwide and in the United States (7, 8) , despite substantial evidence that early referral to a nephrologist reduces mortality and progression of kidney disease (9) . The factors involved in delay in nephrology referral are multi-dimensional, including patient-related (denial of disease, compliance with medical care, fear of dialysis etc.), physician-related (e.g. quality of training and poor communication) and healthcare structure-related (e.g. health insurance) (10) . Another important factor is socioeconomic status, with poor socioeconomic status being a major predictor for delayed referral (11) . This has led to racial disparity in referral patterns since poverty is more closely associated with racial minorities. While race has been associated with delay in nephrology referral (12) , there is a lack of data about the racial disparities in nephrology referral especially in the context of black compared to white race and to our knowledge there are no studies of race disparities that may occur when rate of CKD progression is used as the indication for referral.
Fast rate of estimated glomerular filtration rate (eGFR) decline is associated with adverse renal outcomes (13) and mortality (14) . The major risk factors associated with rapid CKD progression include proteinuria, hypertension, metabolic acidosis, genetics [e.g. apolipoprotein-1 (APOL1) high risk alleles], heart failure, smoking, obesity, lack of physical activity, frailty and depression (15) . The rate of eGFR decline is also significantly influenced by race with blacks, Latinos and Asians showing a faster rate of progression compared to whites due to both genetic and non-genetic (including socio-economic) factors (16, 17) .
US guidelines recommend that patients with eGFR < 30 ml/ min/1.73 m 2 should be referred to a nephrologist (18) , but rate of GFR decline has not been included in clinical guidelines for referral. It has been suggested that the trajectory of GFR decline may be more important than the stage of CKD in making management decisions (19) and involvement of a nephrologist in medical management has been associated with reduction in the rate of progression in CKD (20, 21) . There is, however a lack of data on the appropriate timings of referral for patients with a rapid rate of GFR decline (22, 23) . To address these gaps in the literature, we sought to determine if rate of CKD progression in primary care patients was associated with referral to nephrology and if race disparities exist in the association between rate of CKD progression and referral.
Methods

Subjects
Patient data were obtained from electronic health record (EHR) data generated during clinic visits to any of Saint Louis University (SLU) School of Medicine's three academic family medicine clinics and three general internal medicine clinics located in the urban and suburban St. Louis metropolitan area. De-identified EHR data was extracted from 1 July 2008 to 30 June 2015 and used to create the Department of Family and Community Medicine's Primary Care Patient Data (PCPD) Registry. The PCPD Registry contains data from 33 661 primary care patients. Data used for analysis include ICD-9-CM codes, prescription orders, CPT codes, social history, family history, demographics, laboratory orders, referrals and vital signs. The creation of this retrospective cohort and its use for primary care research was approved by the SLU Institutional Review Board. Additional PCPD Registry details have been previously reported (24) (25) (26) (27) .
The analytic cohort was created by first limiting the sample to patients age 18 and older (n = 31 569) who were either of white or black race (n = 29 490). Each patient must have had a minimum of two eGFR values which reduced the sample to 2268. After excluding 83 patients with a diagnosis of end stage renal disease (ESRD), kidney transplant, acute kidney injury (AKI), dialysis or CKD stage 5 (eGFR < 15 ml/min/1.73 m 2 ) and 15 patients with missing demographic data, the final analytic cohort contained 2170 patients.
Study design
We treated the observation period, 2008-2015, as a cross-section. Rate of eGFR decline and race were the predictor variables and the outcome was referral to nephrology. Race was a patient reported field contained in the EHR. Rate of eGFR decline was computed retrospectively by comparing subsequent eGFR values from prior values for each patient. For example, if a patient had five measurements, eGFR value 5 was compared to value 4, 4 to 3, 3 to 2 and 2 to 1. The calculation for rate of decline was (eGFR measurement 2 -eGFR measurement 1)/(time between measurements in years). If any pairwise comparison in measurements for a patient was at least a 5 unit decrease per year, the eGFR decline was classified as 'fast progression', otherwise change in eGFR was defined as 'slow progression'. Referral to nephrology was identified by an EHR specific referral code.
Covariates included gender, marital status, neighbourhood socioeconomic status (nSES) and high clinic utilization. Comorbid conditions were selected because they are associated with progression and adverse outcomes associated with CKD and included hypertension (28), type 2 diabetes (29), obesity (30), current smoking (31) and metabolic acidosis (crudely reflected by plasma CO 2 which is a surrogate of serum HCO3 in the lab) (32) . We also stratified our cohort into three initial eGFR categories. eGFR≥ 60 ml/ min/1.73 m 2 , GFR> 45 to <60 ml/min/1.73 m 2 (CKD stage 3a) and <45 ml/min/1.73 m 2 (CKD stage 3b or 4). As mentioned, patients with CKD stage 5 (eGFR <15 ml/min/1.73 m 2 ) were excluded from this study. Each eGFR category was used as a covariate. The initial serum creatinine (Cr) was also used as covariate. The laboratory used to run labs for patients in this registry are Quest Diagnostics, LabCorp and SLU hospital labs. Quest and SLU lab use enzymatic assay to measure serum Cr; while LabCorp uses the colorimetric method. For eGFR, SLU lab uses the Modification of Diet in Renal Disease (MDRD) while Quest and LabCorp use the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations.
nSES has been described elsewhere (33) and accounts for zip code level census estimates for percent of households below poverty, receiving public assistance and with income below $35 000 as well as percent of adult males in the labour force, percent of adults with less than a high school education, median household income and median value of single family homes. High health care utilization was used to control for detection bias and was determined by computing the average number of clinic visits per month and dividing the distribution into quartiles where the highest quartile of health care use was compared to all other levels. Hypertension and type 2 diabetes were defined by ICD-9-CM codes. Obesity was defined by body mass index (30.0 kg/m 2 or above) and/or an ICD-9-CM diagnosis (278.00). Lastly, current smoking was derived from the social history file.
Analytic approach
Treating the observation period as a cross-section, the distribution of nephrology referral and covariates were compared between fast and slow eGFR progression and separately by race. Measures of association were estimated using chi-square tests for categorical variables and independent samples t-tests for continuous variables. Separate unadjusted logistic regression models using odds ratios and 95% confidence intervals were computed to measure the associations between eGFR progression, race and all covariates with nephrology referral. An adjusted model included eGFR progression, race and all covariates. Lastly, average eGFR values closest to or on the date of nephrology referral were compared by CKD progression and race using independent samples t-tests.
Results
As shown in Table 1 , the average age of eligible patients was 59.5 (SD ± 15.1), 40.5% were black and 33.8% were male. Nephrology referrals were significantly more prevalent among patients with fast CKD progression compared to patients with slow progression (5.6 versus 2.0%, P < 0.0001). Patients who were older and black were significantly more likely to be fast progressors (P < 0.001). High nSES was more prevalent among slow progressors (P = 0.042). High health care utilization, hypertension, type 2 diabetes and obesity were all significantly more common among those with fast progression. Gender, marital status, smoking, plasma CO 2 (closest to time of referral), initial serum Cr and initial eGFR categories (≥60, >45 to <60 and <45 ml/min/1.73 m 2 ) were not significantly associated with CKD progression.
As shown in Table 2 , the prevalence of nephrology referral was significantly greater in black compared to white patients (P < 0.0001). Fast eGFR decline was more common among black patients as were hypertension, diabetes mellitus, obesity, a higher initial serum Cr and initial eGFR<60 ml/min/1.73 m 2 (P < 0.0001). Male gender, currently married and high nSES were all significantly (P < 0.0001) more prevalent among white patients. High clinic utilization, plasma CO 2 and smoking did not differ between the two races.
Unadjusted bivariate associations between rate of eGFR progression, demographics and comorbid conditions with nephrology referral are shown in Table 3 . Compared to those with slow CKD progression, fast progressors were 2.97 (95% CI: 1.82-4.84) times more likely to receive nephrology referral. Black compared to white patients were 3.47 times more likely to receive nephrology referral (OR = 3.47; 95% CI: 2.11-5.71). Older age and male gender were significantly associated with greater odds of referral and patients who were married and had a high nSES were significantly less likely to be referred to nephrology. Except for smoking and plasma CO 2 Results of a multivariate logistic regression model, estimating the association between fast eGFR decline and race with odds of nephrology referral after adjusting for covariates are shown in Table 4 . Fast progressors and black race had similar magnitude of association with nephrology referral (OR = 2.79; 95% CI: 1.59-4.89 and OR = 2.80; 95% CI: 1.43-5.48, respectively). In multivariate models, age was inversely associated with odds of nephrology referral. Male gender, type 2 diabetes and initial eGFR < 60 (and especially < 45 ml/min/1.73 m 2 ), were each significantly associated with greater odds of nephrology referral. The interaction of race and eGFR progression was tested and found to be non-significant, indicating no differential effect of eGFR progression and referral by race (P value for interaction = 0.468; Table 4 ). Among the 75 patients referred to nephrology, 65 had an eGFR value prior to, or on, the referral date. In these patients, the overall average eGFR closest to or on referral date was 42.8 (SD ± 20.7) with a range of 15.0-105.0. Average eGFR value closest to or on referral was not significantly different between fast and slow progressors (mean = 40.1, SD ± 18.8 versus mean = 48.3 ± 23.6, respectively, P = 0.134). The average eGFR was significantly greater among whites compared to black patients (mean = 51.5 ± 24.5 versus 39.1 ± 17.9, respectively, P = 0.027) closest to or at the time of nephrology referral.
Discussion
In a large sample of primary care patients, we observed that those with fast CKD progression are more likely to be referred to nephrologists than slow progressors, however, a majority of patients are not referred. The second key finding is that black patients, a subgroup more likely to have faster eGFR decline, were also more likely to be referred to nephrology compared to whites. However, the effect of eGFR progression on referral did not differ by race (no interaction, Table 4 ). The third key finding is that initial eGFR<60 ml/min/1.73 3a) . The fourth important observation we made was that, while there was no difference in the eGFR value closest to before or on referral date between fast and slow progressors, the value was significantly higher among whites compared to black patients. Thus, while we found no race disparity in the association of rate of eGFR decline and referral to nephrology, it is possible that one exists in that black patients had more advanced CKD when referred to nephrology.
Better nephrology referral provides a great opportunity to enhance the quality of care of patients with CKD. A survey of 124 PCPs and 120 nephrologists showed that both physicians preferred collaboration in the care of CKD patients (34) . Improving the quality and timing of nephrology referral using an electronic population management database for risk stratification in a large US health care was shown to significantly improve the quality of advanced CKD care, providing a model for practice improvement (35) . The present referral patterns and recommendations are based on the current level of renal function (eGFR) rather than its trajectory over time. Fast eGFR decline has been associated with poor outcomes including ESRD (13) and death (14) , hence it would make sense to use the data of rate of progression in making decisions for nephrology referral. However there is lack of data about the association of rapid CKD progression with nephrology referral patterns. An online survey of 479 internal medicine residents across the United States showed significant variability in the perceptions about the timing of nephrology referral, although most would refer a patient with fast progression of CKD (defined as drop in eGFR from 70 to 50 ml/min/1.73 m2 in 1 year) (36) . To our knowledge, this is the first report of the association between rate of eGFR progression and nephrology referral, and likely the first study evaluating race disparities in the association of rate of progression and referral.
In our cohort of 2170 adult patients seen in primary care clinics, we found that fast CKD progression was associated with older age, black race, low nSES, hypertension, type 2 diabetes and obesity consistent with previous studies. Like previous studies we found no correlation between eGFR progression and smoking (31), however, unlike other studies we did not find an association with gender (29) or with metabolic acidosis (plasma CO 2 ) (32). Potential explanation for this is that our cohort type may be different from others since we excluded patients with AKI, CKD Stage 5 and ESRD. Our finding that patients with fast CKD progression were referred more frequently than slow progressors, suggests appropriate practice by the PCPs in the clinics we studied. However we cannot say if the rate of GFR decline (rather than the last eGFR value) was used by the PCP in making the referral decision. What is quite concerning is the finding that most of the patients with fast eGFR decline were not referred and reveals a major area of practice improvement.
There is a lack of data with regard to racial disparities in nephrology referral. Among the possible reasons for delayed referral noted in minorities and patients of lower socio-economic class are poor access to health care and lack of awareness of kidney disease (12) . As noted in several previous studies (16, 37) , black race was associated with many factors that lead to kidney disease and/or its progression including lower initial GFR, hypertension, diabetes mellitus, obesity and lower socio-economic class. While, our finding that blacks were referred more frequently to the nephrologist also suggests an appropriate referral pattern based on their disease burden, we also observe that eGFR around the time of referral was significantly lower in blacks compared to whites. It remains to be determined if this disparity is due to a delay in referral secondary to physician, patient or healthcare system associated factors or due to faster rates of decline in blacks. In a recent study looking at referral patterns for transplantation among dialysis patients, it was noted that black patients were more likely to be referred compared to whites (38) . In primary care, it might be more appropriate to have more frequent renal assessment of black patients (who are at higher risk of CKD progression) to catch a significant eGFR decline early and ensure a more timely referral. Further studies are required to test this hypothesis. The observation that initial eGFR <60 ml/min/1.73 m 2 was not associated with fast CKD progression is quite interesting. This suggests that a significant proportion of the people with eGFR >60 ml/ min/1.73 m 2 (i.e. not considered to have significant kidney disease), have a fast rate of eGFR decline and are at high risk for adverse outcomes. In Table 3 , we show that 843 (40.2%) patients who were not referred to the nephrology clinic had a fast eGFR decline, and it is likely that a significant number of these patients had an eGFR >60 ml/min/1.73 m 2 and consequently not considered appropriate for referral by PCPs. This conclusion is also supported by our observation that the mean eGFR near the time of referral was < 60 ml/ min/1.73 m 2 . This finding provides stimulus for further research in patients with early kidney disease in identifying those with high risk of adverse outcomes and how improvement in their quality of care potentially including earlier referral to nephrologists would lead to better outcomes. Potential methods to improve referral patterns include increasing public awareness about CKD (e.g. via community-based screening) and better education of primary providers in identifying patients with high risk of CKD progression (e.g. using eGFR trajectories in the EHR). Whether these measures result in better outcomes needs to tested in prospective studies.
A limitation of this study is some variability in the measurement of eGFR and serum Cr by each laboratory, although this variability is likely to be minimal and not affect the study conclusions. We do not know which laboratory value (serum Cr or eGFR) the PCPs used in making the decision for nephrology referral. We also did not have data for proteinuria which has also been associated with eGFR progression and adverse outcomes in CKD (29) . We cannot rule out residual confounding, although we attempted to minimize this by including most of the important covariates associated with CKD and using established definitions. Our design was cross-sectional and we cannot account for the exact timing of nephrology referral with respect of the GFR decline, however 87% of patients referred had eGFR values before referral. Lastly, our cohort was restricted to the Saint Louis metropolitan region and did not include a significant number of patients from rural areas or those from non-black, nonwhite ethnicities, limiting the external validity of our study (39) .
Our results suggest the rate of decline, and not only absolute eGFR value could be considered in decisions to refer patients to nephrology, however more studies are required. Further research is needed to prospectively evaluate if lower eGFR values among blacks at time of nephrology referral points to a true disparity in quality of care or represents the effect of more rapid CKD decline in black patients. Lastly, quality improvement initiatives are warranted to improve on the percent of patients referred to nephrology at high risk of CKD progression, including those with eGFR >60 ml/min/1.73 m 2 .
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